Supplementary Data from Entinostat Decreases Immune Suppression to Promote Antitumor Responses in a HER2⁺ Breast Tumor Microenvironment حسب Dimitrios N. Sidiropoulos (8812874)

Supplementary Data from Entinostat Decreases Immune Suppression to Promote Antitumor Responses in a HER2⁺ Breast Tumor Microenvironment حسب Dimitrios N. Sidiropoulos (8812874)

Supplementary Data from Entinostat Decreases Immune Suppression to Promote Antitumor Responses in a HER2⁺ Breast Tumor Microenvironment حسب Dimitrios N. Sidiropoulos (8812874)

Supplementary Data from Entinostat Decreases Immune Suppression to Promote Antitumor Responses in a HER2⁺ Breast Tumor Microenvironment حسب Dimitrios N. Sidiropoulos (8812874)

Supplemental Table 1 Kinase Inhibitor Screen from Activation of PP2A and Inhibition of mTOR Synergistically Reduce MYC Signaling and Decrease Tumor Growth in Pancreatic Ductal Aden... حسب Brittany L. Allen-Petersen (14935217)

Figure 1 from SMG8/SMG9 Heterodimer Loss Modulates SMG1 Kinase to Drive ATR Inhibitor Resistance حسب Marta J. Llorca-Cardenosa (14961612)

"…<p>Gastric cancer genome-wide CRISPRn screen identifies genetic determinants of ATRi resistance. <b>A,</b> YCC6 and SNU5 gastric tumor cell lines show no ARID1A expression by Western blotting. …"

mRNA expression levels of NeuroD1 and GPX4 in clinical tumor samples. حسب Ping Huang (30439)

الموضوعات:

FIGURE 3 from PARP Inhibitors Effectively Reduce MAPK Inhibitor Resistant Melanoma Cell Growth and Synergize with MAPK Inhibitors through a Synthetic Lethal Interaction <i>In Vitro... حسب Lisa Marie Fröhlich (16838353)

"…<p>MAPKi resistant cells show decreased ATM expression. <b>A,</b> Immunoblot analysis of A375 R cells treated with 5 μmol/L talazoparib (Tala.) for 24 hours or untreated (Ctr.). …"

CCR Translation for This Article from Controlled Local Delivery of CTLA-4 Blocking Antibody Induces CD8⁺ T-Cell–Dependent Tumor Eradication and Decreases Risk of Toxic S... حسب Marieke F. Fransen (3699181)

Supplementary Table 3 from MyD88-Dependent Signaling Decreases the Antitumor Efficacy of Epidermal Growth Factor Receptor Inhibition in Head and Neck Cancer Cells حسب Adam T. Koch (14919645)

Supplementary Table 1 from MyD88-Dependent Signaling Decreases the Antitumor Efficacy of Epidermal Growth Factor Receptor Inhibition in Head and Neck Cancer Cells حسب Adam T. Koch (14919645)

Supplementary Table 2 from MyD88-Dependent Signaling Decreases the Antitumor Efficacy of Epidermal Growth Factor Receptor Inhibition in Head and Neck Cancer Cells حسب Adam T. Koch (14919645)

Supplementary Figure 3 from MyD88-Dependent Signaling Decreases the Antitumor Efficacy of Epidermal Growth Factor Receptor Inhibition in Head and Neck Cancer Cells حسب Adam T. Koch (14919645)

Supplementary Figure 2 from MyD88-Dependent Signaling Decreases the Antitumor Efficacy of Epidermal Growth Factor Receptor Inhibition in Head and Neck Cancer Cells حسب Adam T. Koch (14919645)

Supplementary Figure 4 from MyD88-Dependent Signaling Decreases the Antitumor Efficacy of Epidermal Growth Factor Receptor Inhibition in Head and Neck Cancer Cells حسب Adam T. Koch (14919645)

Supplementary Figure 1 from MyD88-Dependent Signaling Decreases the Antitumor Efficacy of Epidermal Growth Factor Receptor Inhibition in Head and Neck Cancer Cells حسب Adam T. Koch (14919645)

Cabozantinib treatment decreased microvessel density, but not proliferation and increased hypoxic stress in LuCaP 93 and LuCaP 173.1 patient-derived xenografts. حسب Mark P. Labrecque (10011469)

The competition between shear stress and junction force transmission results from the inverse relationship between cell number and flow resistance. حسب Lowell T. Edgar (10099338)

"…Similarly, increases in cell number result in a drop in resistance and the pressure drop, which decreases the amount of shear stress present in the vessel.…"

Supplementary Table 1-2, Figures S1-4 from siRNA Lipid Nanoparticle Potently Silences Clusterin and Delays Progression When Combined with Androgen Receptor Cotargeting in Enzalutam... حسب Yoshiaki Yamamoto (2920581)

Supplementary Figures S1-S11 from The Novel, Small-Molecule DNA Methylation Inhibitor SGI-110 as an Ovarian Cancer Chemosensitizer حسب Fang Fang (38179)

"…Data shown represent means {plus minus} S.E.M. from 5 tumors. Supplementary Figure S9. Decrease of tumor growth of parental and resistant-derived A2780 xenografts treated by SGI-110 and CDDP in the QD5 and biweekly regimens. …"